First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis : A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales

Kerr, S, Joy, M, Torabi, F, Bedston, S, Akbari, A, Agrawal, U, Beggs, J, Bradley, D, Chuter, A, Docherty, A B, Ford, D, Hobbs, R, Katikireddi, S V, Lowthian, E, de Lusignan, S, Lyons, R, Marple, J, McCowan, C, McGagh, D, McMenamin, J, Moore, E, Murray, J L K, Owen, R K, Pan, J, Ritchie, L, Shah, S A, Shi, T, Stock, S, Tsang, R S M, Vasileiou, E, Woolhouse, M, Simpson, C R, Robertson, C & Sheikh, A 2022, 'First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis : A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales', PLoS Medicine, vol. 19, no. 2, e1003927. https://doi.org/10.1371/journal.pmed.1003927